• News
    • General
    • World News
    • Education
    • Climate
    • Covid-19
    • Featured Zone - Our Clients
    • Organisation
    • Politics
    • Healthcare
    • Photo Gallery
    • Pharma
  • Business
    • Business News
    • Market Updates
    • Economy
    • Personal Finance
    • Stock Market
    • Food & Beverages
    • Energy
    • Business Sectors
    • Business Assets
    • Insurance
    • Commodities
    • Banking and Investment
    • IPO
    • Real Estate
    • Cryptocurrency
  • Trending Stocks
    • Dividend Stocks
    • Penny Stocks
    • Value Stocks
    • Growth Stocks
    • Bluechip Stocks
    • Smallcap Stocks
    • Midcap Stocks
    • Lithium Stocks
    • Gold Stocks
    • Technology Stocks
    • Cannabis Stocks
    • Metal & Mining Stocks
    • Healthcare Stocks
    • Financial Stocks
    • Oil and Gas Stocks
    • Retail Stocks
    • Technical Analysis
    • Consumer Stocks
    • Infra & Real Estate Stocks
    • Communication Stocks
    • Industrial Stocks
  • Companies
  • Entertainment
    • Entertainment
    • Arts & Books
    • Fashion
    • Luxury
    • Travel & Lifestyle
  • Kalkine TV
    • Latest Videos
  • Markets
    • ASX Indices
    • ASX 20
    • ASX 50
    • ASX 100
    • ASX 200
    • ASX 300
    • All Ordinaries
    • All Scans
    • ASX Announcements
    • IPO
    • Cryptocurrency
    • Money
  • Sports
    • Cricket
    • Football
    • Tennis
    • Golf
    • Basketball
    • Formula One
    • Boxing
    • Other Sports
  • Education
    • Science
    • Technology
    • Auto
    • Media & Broadcasting
    • Definition
  • Our Products
    • Events
    • Advertise With Us
    • Magazine
  • Forum

ImpediMed (ASX: IPD): This ASX biotech stock almost doubles in a day. Here's why

  • Mar 27, 2023 AEDT
  • Neha Simpy

This ASX healthcare company receives takeover offer from Bain Capital; shares jump

  • Mar 24, 2023 AEDT
  • Neha Simpy

Healius Limited (ASX: HLS) jumps over 9% on takeover bid from ACL

  • Mar 20, 2023 AEDT
  • Neha Simpy

Neuren Pharmaceuticals’ (ASX:NEU) drug to treat Rett syndrome gets US FDA approval; shares up 20%

  • Mar 13, 2023 AEDT
  • Priyabrata Prusty

Mesoblast (ASX: MSB) shares rally 14% as FDA accepts resubmission of BLA for new therapy

  • Mar 08, 2023 AEDT
  • Neha Simpy

Why are Rhythm Biosciences (ASX: RHY) shares down nearly 50% today

  • Mar 06, 2023 AEDT
  • Neha Simpy

Mayne Pharma Group Ltd (ASX: MYX) surges 28% in 5 days. Here’s why

  • Mar 02, 2023 AEDT
  • Versha Jain

Ramsay Health Care (ASX: RHC) profit rises 22.3% in half year 2023; shares end 3% higher

  • Feb 23, 2023 AEDT
  • Neha Simpy

Cochlear (ASX: COH) HY23 revenue rises 9%, guidance maintained

  • Feb 15, 2023 AEDT
  • Neha Simpy

Why is Mayne Pharma Group (ASX:MYX) in limelight today?

  • Jan 18, 2023 AEDT
  • Aditi Sarkar

Medibank (ASX:MPL) adds AU$207M to COVID-19 support fund

  • Dec 23, 2022 AEDT
  • Tamnna

BWX (ASX:BWX) posts attributable loss of AU$337M

  • Dec 19, 2022 AEDT
  • Sonal Goyal

Know these ASX healthcare penny stocks

  • Dec 14, 2022 AEDT
  • Aditi Sarkar

CSL (ASX:CSL) appoints next CEO and managing director, shares on watch

  • Dec 13, 2022 AEDT
  • Tamnna

What’s up with Nanosonics’ (ASX:NAN) shares today?

  • Dec 13, 2022 AEDT
  • Tamnna

How are Ansell’s (ASX:ANN) shares performing lately?

  • Dec 12, 2022 AEDT
  • Tamnna

Healius’ (ASX:HLS) shares on investors’ radar today, here’s why

  • Dec 09, 2022 AEDT
  • Sonal Goyal

How artificial intelligence can revolutionise the course of precision medicine

  • Dec 04, 2022 AEDT
  • Aditi Sarkar

Fisher & Paykel Healthcare (ASX:FPH) first-half profit falls over 50%

  • Nov 29, 2022 AEDT
  • Tamnna

Why are Microba Life Sciences’ (ASX:MAP) shares up 68%?

  • Nov 29, 2022 AEDT
  • Sonal Goyal
  • ‹
  • 1
  • 2
  • 3
  • 4
  • ...
  • 11
  • 12
  • ›



Copyright © 2023 Kalkine Media Pty Ltd. All Rights Reserved.
ACN: 629 651 672
    Contact us: info@Kalkinemedia.com
    +61 290559495
    Suite 202, 234 George Street, Sydney NSW 2000,Australia
  • Contact Us
  • Advertise with us
  • Disclaimer
  • T&C
  • Privacy
  • Web Content Policy
  • Meet The Team